Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Tetanus Immune Globulin (Human) HyperTET® 250 Units
Medication labelWhy this: Advisory · dailymed-other
HyperTET is indicated for prophylaxis against tetanus following injury in patients whose immunization is incomplete or uncertain (see below). It is also indicated, although evidence of effectiveness is limited, in the regimen of treatment of active cases of tetanus.(8,9,16) A thorough attempt must be made to determine whether a patient has completed primary vaccination. Patients with unknown or uncertain previous vaccination histories should be considered to have had no previous tetanus toxoid doses. Persons who had military service since 1941 can be considered to have received at least one dose, and although most of them may have completed a primary series of tetanus toxoid, this cannot be assumed for each individual. Patients who have not completed a primary series may require tetanus toxoid and passive immunization at the time of wound cleaning and debridement.(3) The following table is a summary guide to tetanus prophylaxis in wound management:
- generic_name
- tetanus immune globulin (human)
- product_names
- Tetanus Immune Globulin (Human)
- ndc
- 13533-634, 13533-634-20, 13533-634-02
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en